The brand new menu of arrays includes whole-transcript expression profiling, genotyping, and gene regulation arrays for organisms such as for example bovine, rice, soybean, porcine, medicago, zebrafish, mosquito, E. Coli, Shigella, maize, and others. In addition, Affymetrix offers more than 30 other arrays for environmental, meals, and infectious disease studies in cartridge, strip, and plate platforms for different throughput needs. ‘We are collaborating with users of consortia through every step of our advancement and manufacturing process to ensure that they get the most out of their array designs.’ Affymetrix and its partners are utilizing the most recent genomic data produced from next-generation sequencing studies to create these arrays.The scheduled system of the Symposium can be dedicated to personalized medication and the future of oncology care, and will be presented by crucial opinion leaders in the field, including:.. Active Biotech, Teva to commence third Phase III research of laquinimod for RRMS Teva Pharmaceutical Sectors Ltd. and Active Biotech provided today an update on the clinical development program of once-daily oral laquinimod for the treating relapsing-remitting multiple sclerosis . The ongoing companies are to initiate a third Phase III study of laquinimod, following the written agreement reached with the U.S.